Related references
Note: Only part of the references are listed.Interobserver Variation of PD-L1 SP142 Immunohistochemistry Interpretation in Breast Carcinoma
Raza S. Hoda et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)
Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes
Lea A. Moukarzel et al.
MODERN PATHOLOGY (2021)
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years
Neelam Desai et al.
CANCER (2021)
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
Nadine M. Tung et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary
Arnaud Paula et al.
MODERN PATHOLOGY (2020)
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma
Raza Syed Hoda et al.
MODERN PATHOLOGY (2020)
Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors
Changxia Shao et al.
JAMA NETWORK OPEN (2020)
No Evidence of Increased Risk of Breast Cancer in Women With Lynch Syndrome Identified by Multigene Panel Testing
Jessica Stoll et al.
JCO PRECISION ONCOLOGY (2020)
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology Concordance Among 3 Commonly Used and Commercially Available Antibodies
Henning Reis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Detecting the mutational signature of homologous recombination deficiency in clinical samples
Doga C. Gulhan et al.
NATURE GENETICS (2019)
SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events
Erik N. Bergstrom et al.
BMC GENOMICS (2019)
Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 Featured Updates to the NCCN Guidelines
Samir Gupta et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
Alicia Latham et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The Genomic Landscape of Mucinous Breast Cancer
Fresia Pareja et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genome-wide somatic variant calling using localized colored de Bruijn graphs
Giuseppe Narzisi et al.
COMMUNICATIONS BIOLOGY (2018)
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
Diana Mandelker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency
Helen Davies et al.
CANCER RESEARCH (2017)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels
Zsofia K. Stadler et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
Ronglai Shen et al.
NUCLEIC ACIDS RESEARCH (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
Charlotte K. Y. Ng et al.
GENOME BIOLOGY (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Accurate de novo and transmitted indel detection in exome-capture data using microassembly
Giuseppe Narzisi et al.
NATURE METHODS (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
DNA Mismatch Repair Deficiency in Breast Carcinoma A Pilot Study of Triple-negative and Non-Triple-negative Tumors
Yong H. Wen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs
Christopher T. Saunders et al.
BIOINFORMATICS (2012)
Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry
Mala Pande et al.
FAMILIAL CANCER (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
Colorectal and Other Cancer Risks for Carriers and Noncarriers From Families With a DNA Mismatch Repair Gene Mutation: A Prospective Cohort Study
Aung Ko Win et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases
Johanna E. Lotsari et al.
BREAST CANCER RESEARCH (2012)
Synchronous Breast Cancers With Different Morphologic and Molecular Phenotypes Occurring in Lynch Syndrome: What Does the Heterogeneity Imply?
Clare D'Arcy et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Somatic Hypermethylation of MSH2 Is a Frequent Event in Lynch Syndrome Colorectal Cancers
Takeshi Nagasaka et al.
CANCER RESEARCH (2010)
Lynch Syndrome-Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry
Michael D. Walsh et al.
CLINICAL CANCER RESEARCH (2010)
Identification of a breast tumor with microsatellite instability in a potential carrier of the hereditary non-polyposis colon cancer trait
Jon Thor Bergthorsson et al.
CLINICAL GENETICS (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Share Paper
